Cargando…
Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis
In a study published recently in Arthritis Research & Therapy, Woo and colleagues investigated the effects of pravastatin in combination with an apolipoprotein-AI (Apo-AI) mimetic peptide in a mouse model of lupus-accelerated atherosclerosis. Combination treatment resulted in a significant decre...
Autores principales: | Mendez-Fernandez, Yanice, Major, Amy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990990/ https://www.ncbi.nlm.nih.gov/pubmed/20854650 http://dx.doi.org/10.1186/ar3115 |
Ejemplares similares
-
ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
por: Edmunds, Shelley J., et al.
Publicado: (2019) -
Apolipoprotein A-I mimetic peptides (ApoAI MP) improve oxidative stress and inflammatory responses in Parkinson’s disease mice
por: Jiang, Hongfang, et al.
Publicado: (2022) -
Aortic Atherosclerosis in Systemic Lupus Erythematosus
por: Roldan, Paola C, et al.
Publicado: (2014) -
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
por: Woo, Jennifer MP, et al.
Publicado: (2010) -
The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE
(−/−) Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus
por: Richez, Christophe, et al.
Publicado: (2013)